Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Molecular Partners AG - American Depositary Shares (NQ:MOLN)

4.003 -0.037 (-0.92%)
Streaming Delayed Price Updated: 3:36 PM EDT, May 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Molecular Partners AG - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Molecular Partners Initiates Clinical Study of Trispecific Candidate MP0533 for the Treatment of Acute Myeloid Leukemia
From Molecular Partners
Via GlobeNewswire
News headline image
Molecular Partners Provides Updates at 41st Annual JPM Healthcare Conference
From Molecular Partners
Via GlobeNewswire
News headline image
Molecular Partners Presents New Preclinical Data Supporting its MP0533 DARPin T-Cell Engager for the Treatment of AML
From Molecular Partners
Via GlobeNewswire
News headline image
Molecular Partners Announces Acceptance of Oral Presentation at the Annual American Society of Hematology Meeting
- Company will also host a reception with Key Opinion Leaders in New Orleans - 
From Molecular Partners
Via GlobeNewswire
News headline image
Molecular Partners Announces Upcoming Participation in Investor and Scientific Conferences
From Molecular Partners
Via GlobeNewswire
News headline image
Interim Management Statement Q3 2022: Continued Progress Across Oncology Programs with First Clinical Data Expected from Phase 1 Trial of MP0317 and Initiation of Phase 1 Trial of MP0533 Anticipated by Year-End
From Molecular Partners
Via GlobeNewswire
News headline image
Molecular Partners Announces Planned Departure of Chief Financial Officer
From Molecular Partners
Via GlobeNewswire
News headline image
Molecular Partners AG (NASDAQ:MOLN) Long Term Investor Alert: Investigation of Potential Wrongdoing ↗
San Diego, CA -- (SBWIRE) -- 10/26/2022 -- An investigation was announced for current long-term investors in shares of Molecular Partners AG (NASDAQ:MOLN) concerning potential breaches of fiduciary... 
Via SBWire
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Gainers NeuroMetrix (NASDAQ:NURO) shares increased by 23.0% to $3.48 during Monday's pre-market session. The company's market cap stands at $24.8 million. 
Via Benzinga
News headline image
NASDAQ:MOLN Investor Notice: Deadline Coming Up on September 12, 2022 in Lawsuit Against Molecular Partners AG ↗
San Diego, CA -- (SBWIRE) -- 09/12/2022 -- A deadline is coming up on September 12, 2022 in the lawsuit filed for certain investors of Molecular Partners AG (NASDAQ:MOLN). 
Via SBWire
News headline image
Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Molecular Partners AG (MOLN) Investors of Class Action and Last Few Hours to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
News headline image
FINAL INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Molecular Partners AG with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
MOLN DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages Molecular Partners AG Investors With Losses to Secure Counsel Before Important September 12 Deadline in Securities Class Action - MOLN
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
News headline image
MOLECULAR PARTNERS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Molecular Partners AG and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
News headline image
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Molecular Partners AG Investors to Secure Counsel Before Important Deadline in Securities Class Action - MOLN
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
  
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  On Tuesday, 250 stocks hit new 52-week lows. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 29, 2022 ↗
Upgrades 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
  
Via Benzinga
News headline image
SVB Leerink Slashes Price Target On This Stock By Over 73%, Plus This Analyst Predicts $56 For Toll Brothers ↗
Citigroup raised the price target for MacroGenics, Inc. (NASDAQ: MGNX) from $13 to $16. MacroGenics shares rose 4.8% to $3.90 in pre-market trading. 
Via Benzinga
News headline image
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Molecular Partners AG Investors to Secure Counsel Before Important Deadline in Securities Class Action - MOLN
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
News headline image
Earnings Scheduled For August 25, 2022 ↗
Companies Reporting Before The Bell • Gold Fields (NYSE:GFI) is likely to report earnings for its first quarter. • 111 (NASDAQ:YI) is projected to report earnings for its second quarter. 
Via Benzinga
News headline image
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Molecular Partners AG Investors to Secure Counsel Before Important Deadline in Securities Class Action - MOLN
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
News headline image
NASDAQ: MOLN Shareholder Notice: Lawsuit Alleges Misleading Statements by Molecular Partners AG ↗
San Diego, CA -- (SBWIRE) -- 08/16/2022 -- An investor, who purchased shares of Molecular Partners AG (NASDAQ: MOLN), filed a lawsuit over alleged violations of Federal Securities Laws by Molecular... 
Via SBWire
News headline image
ROSEN, A LEADING AND RANKED FIRM, Encourages Molecular Partners AG Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - MOLN
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
News headline image
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Molecular Partners AG Investors to Secure Counsel Before Important Deadline in Securities Class Action - MOLN
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
News headline image
Molecular Partners AG Investigation: Robbins LLP is Investigating Molecular Partners AG (MOLN) on Behalf of Shareholders
From Robbins LLP
Via Business Wire
News headline image
ROSEN, LEADING INVESTOR COUNSEL, Encourages Molecular Partners AG Investors to Secure Counsel Before Important Deadline in Securities Class Action - MOLN
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
News headline image
Bronstein, Gewirtz & Grossman, LLC Notifies Molecular Partners AG (MOLN) Investors of Class Action and Encourages Investors to Contact the Firm
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
News headline image
INVESTOR NOTICE: Molecular Partners AG Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - MOLN
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.